vs

Side-by-side financial comparison of Church & Dwight (CHD) and STEPAN CO (SCL). Click either name above to swap in a different company.

Church & Dwight is the larger business by last-quarter revenue ($1.6B vs $553.9M, roughly 3.0× STEPAN CO). Church & Dwight runs the higher net margin — 8.7% vs 0.9%, a 7.8% gap on every dollar of revenue. On growth, STEPAN CO posted the faster year-over-year revenue change (5.4% vs 3.9%). Over the past eight quarters, Church & Dwight's revenue compounded faster (4.6% CAGR vs 0.2%).

Church & Dwight Co., Inc., is an American consumer goods company focusing on personal care, household products, and specialty products. The company was founded in 1847 and is headquartered in Ewing, New Jersey. It is the parent company of well-known brands such as Arm & Hammer, Trojan, OxiClean, and First Response. In 2022, Church & Dwight reported annual revenue of $5.4 billion. The company's products and services include a wide range of consumer goods, including laundry detergent, air fresh...

Stepan Company is an American manufacturer of specialty chemicals headquartered in Northbrook, Illinois. The company was founded in 1932 by Alfred C. Stepan, Jr., and has approximately 2,000 employees. It is currently run by his grandson, F. Quinn Stepan, Jr. The company describes itself as the largest global merchant manufacturer of anionic surfactants, which are used to enhance the foaming and cleaning capabilities of detergents, shampoos, toothpastes, and cosmetics.

CHD vs SCL — Head-to-Head

Bigger by revenue
CHD
CHD
3.0× larger
CHD
$1.6B
$553.9M
SCL
Growing faster (revenue YoY)
SCL
SCL
+1.4% gap
SCL
5.4%
3.9%
CHD
Higher net margin
CHD
CHD
7.8% more per $
CHD
8.7%
0.9%
SCL
Faster 2-yr revenue CAGR
CHD
CHD
Annualised
CHD
4.6%
0.2%
SCL

Income Statement — Q4 2025 vs Q4 2025

Metric
CHD
CHD
SCL
SCL
Revenue
$1.6B
$553.9M
Net Profit
$143.5M
$5.0M
Gross Margin
45.8%
9.3%
Operating Margin
16.2%
1.9%
Net Margin
8.7%
0.9%
Revenue YoY
3.9%
5.4%
Net Profit YoY
-24.2%
49.4%
EPS (diluted)
$0.60
$0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHD
CHD
SCL
SCL
Q4 25
$1.6B
$553.9M
Q3 25
$1.6B
$590.3M
Q2 25
$1.5B
$594.7M
Q1 25
$1.5B
$593.3M
Q4 24
$1.6B
$525.6M
Q3 24
$1.5B
$546.8M
Q2 24
$1.5B
$556.4M
Q1 24
$1.5B
$551.4M
Net Profit
CHD
CHD
SCL
SCL
Q4 25
$143.5M
$5.0M
Q3 25
$182.2M
$10.8M
Q2 25
$191.0M
$11.3M
Q1 25
$220.1M
$19.7M
Q4 24
$189.2M
$3.4M
Q3 24
$-75.1M
$23.6M
Q2 24
$243.5M
$9.5M
Q1 24
$227.7M
$13.9M
Gross Margin
CHD
CHD
SCL
SCL
Q4 25
45.8%
9.3%
Q3 25
45.1%
12.0%
Q2 25
43.0%
12.1%
Q1 25
45.0%
12.7%
Q4 24
44.7%
10.8%
Q3 24
45.2%
13.8%
Q2 24
47.1%
12.5%
Q1 24
45.7%
12.7%
Operating Margin
CHD
CHD
SCL
SCL
Q4 25
16.2%
1.9%
Q3 25
16.1%
3.7%
Q2 25
17.4%
3.0%
Q1 25
20.1%
4.8%
Q4 24
16.2%
1.5%
Q3 24
-6.1%
4.4%
Q2 24
22.3%
3.4%
Q1 24
20.3%
3.7%
Net Margin
CHD
CHD
SCL
SCL
Q4 25
8.7%
0.9%
Q3 25
11.5%
1.8%
Q2 25
12.7%
1.9%
Q1 25
15.0%
3.3%
Q4 24
12.0%
0.6%
Q3 24
-5.0%
4.3%
Q2 24
16.1%
1.7%
Q1 24
15.1%
2.5%
EPS (diluted)
CHD
CHD
SCL
SCL
Q4 25
$0.60
$0.22
Q3 25
$0.75
$0.47
Q2 25
$0.78
$0.50
Q1 25
$0.89
$0.86
Q4 24
$0.76
$0.14
Q3 24
$-0.31
$1.03
Q2 24
$0.99
$0.42
Q1 24
$0.93
$0.61

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHD
CHD
SCL
SCL
Cash + ST InvestmentsLiquidity on hand
$409.0M
$132.7M
Total DebtLower is stronger
$2.2B
$626.7M
Stockholders' EquityBook value
$4.0B
$1.2B
Total Assets
$8.9B
$2.4B
Debt / EquityLower = less leverage
0.55×
0.50×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHD
CHD
SCL
SCL
Q4 25
$409.0M
$132.7M
Q3 25
$305.3M
$118.5M
Q2 25
$923.2M
$88.9M
Q1 25
$1.1B
$107.5M
Q4 24
$964.1M
$99.7M
Q3 24
$752.1M
$147.3M
Q2 24
$491.7M
$124.7M
Q1 24
$349.7M
$125.8M
Total Debt
CHD
CHD
SCL
SCL
Q4 25
$2.2B
$626.7M
Q3 25
$2.2B
$655.5M
Q2 25
$2.2B
$658.0M
Q1 25
$2.2B
$659.3M
Q4 24
$2.2B
$625.4M
Q3 24
$2.2B
$688.5M
Q2 24
$2.2B
$657.1M
Q1 24
$2.2B
$646.0M
Stockholders' Equity
CHD
CHD
SCL
SCL
Q4 25
$4.0B
$1.2B
Q3 25
$4.2B
$1.2B
Q2 25
$4.4B
$1.2B
Q1 25
$4.6B
$1.2B
Q4 24
$4.4B
$1.2B
Q3 24
$4.2B
$1.2B
Q2 24
$4.3B
$1.2B
Q1 24
$4.1B
$1.2B
Total Assets
CHD
CHD
SCL
SCL
Q4 25
$8.9B
$2.4B
Q3 25
$9.1B
$2.4B
Q2 25
$8.8B
$2.4B
Q1 25
$9.0B
$2.4B
Q4 24
$8.9B
$2.3B
Q3 24
$8.7B
$2.4B
Q2 24
$8.8B
$2.3B
Q1 24
$8.6B
$2.4B
Debt / Equity
CHD
CHD
SCL
SCL
Q4 25
0.55×
0.50×
Q3 25
0.52×
0.53×
Q2 25
0.50×
0.53×
Q1 25
0.48×
0.55×
Q4 24
0.51×
0.53×
Q3 24
0.53×
0.56×
Q2 24
0.51×
0.55×
Q1 24
0.54×
0.53×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHD
CHD
SCL
SCL
Operating Cash FlowLast quarter
$60.0M
Free Cash FlowOCF − Capex
$25.4M
FCF MarginFCF / Revenue
4.6%
Capex IntensityCapex / Revenue
3.4%
6.3%
Cash ConversionOCF / Net Profit
11.99×
TTM Free Cash FlowTrailing 4 quarters
$25.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHD
CHD
SCL
SCL
Q4 25
$60.0M
Q3 25
$69.8M
Q2 25
$11.2M
Q1 25
$6.9M
Q4 24
$292.3M
$68.3M
Q3 24
$364.0M
$22.7M
Q2 24
$236.9M
$29.5M
Q1 24
$263.0M
$41.6M
Free Cash Flow
CHD
CHD
SCL
SCL
Q4 25
$25.4M
Q3 25
$40.2M
Q2 25
$-14.4M
Q1 25
$-25.8M
Q4 24
$237.7M
$32.1M
Q3 24
$315.4M
$-4.0M
Q2 24
$206.6M
$-208.0K
Q1 24
$216.7M
$11.4M
FCF Margin
CHD
CHD
SCL
SCL
Q4 25
4.6%
Q3 25
6.8%
Q2 25
-2.4%
Q1 25
-4.3%
Q4 24
15.0%
6.1%
Q3 24
20.9%
-0.7%
Q2 24
13.7%
-0.0%
Q1 24
14.4%
2.1%
Capex Intensity
CHD
CHD
SCL
SCL
Q4 25
3.4%
6.3%
Q3 25
1.8%
5.0%
Q2 25
1.5%
4.3%
Q1 25
1.1%
5.5%
Q4 24
3.5%
6.9%
Q3 24
3.2%
4.9%
Q2 24
2.0%
5.3%
Q1 24
3.1%
5.5%
Cash Conversion
CHD
CHD
SCL
SCL
Q4 25
11.99×
Q3 25
6.44×
Q2 25
0.99×
Q1 25
0.35×
Q4 24
1.54×
20.38×
Q3 24
0.96×
Q2 24
0.97×
3.10×
Q1 24
1.16×
2.99×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CHD
CHD

Household Products$645.3M39%
Personal Care Products$625.9M38%
Consumer International$299.8M18%
Specialty Products Division$73.2M4%

SCL
SCL

Surfactants$401.8M73%
Polymers$131.7M24%
Specialty Products$20.4M4%

Related Comparisons